Pfizer seeks expedited approval to make BioNTech vaccine available in India-Health News , Firstpost
Coronavirus LIVE Updates: Pfizer chief Albert Bourla said that even though the company had submitted its application for approval ‘months ago’, the vaccine is still not registered in India
Coronavirus LIVE Updates: Global Pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine available for use in the country, the company’s Chairman and CEO Albert Bourla said on Monday. Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India.
“Pfizer is aware that access to vaccines is critical to ending this pandemic. Unfortunately, our vaccine is not registered in India although our application was submitted months ago. We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country,” Bourla said in a mail sent to Pfizer India employees that he has shared on his LinkedIn post.
The Delhi High Court on Monday directed the Centre to take instructions on the communication by AAP government to the Union Defence Minister requesting help of the Army to set up COVID health facilities with oxygenated and ICU beds to treat COVID-19 patients as well as supply cryogenic tanker for oxygen.
Delhi has sought the help of the Army to set up, operationalise and run some COVID-19 health facilities with about 10,000 oxygenated non-ICU beds and 1,000 ICU beds, said reports. In a letter to Defence Minister Rajnath Singh, Sisodia also requested the defence ministry to make arrangement for the transportation of medical oxygen to the facilities to be set up.
Madhya Pradesh chief minister Shivraj Singh Chouhan on Monday said all accredited journalists in the state will be considered as frontline workers.
The Delhi High Court is hearing a plea seeking directions to hand over the management of oxygen stocks in the national capital to the Army to ensure an uninterrupted supply to hospitals.
The daily COVID-19 cases in India showed a slight dip with 3,68,147 new coronavirus infections being reported in a day, taking the total tally of cases to 1,99,25,604, according to the Union Health Ministry data updated on Monday.
The death toll increased to 2,18,959 with 3,417 daily new fatalities, the data updated at 8 am showed.
While the country recorded 4,01,993 new cases on May 1, it had registered 3,92,488 fresh cases on May 2.
Registering a steady increase, the active cases have increased to 34,13,642 comprising 17.13 per cent of the total infections, while the national COVID-19 recovery rate stands at 81.77 per cent.
The number of people who have recuperated from the disease surged to 1, 62,93,003, while the case fatality rate was recorded at 1.10 per cent, the data stated.
India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19. India crossed the grim milestone of 1.50 crore on April 19.
According to the ICMR, 29,16,47,037 samples have been tested up to May 2 with 15,04,698 samples being tested on Sunday.
The 3,417 new fatalities include 669 from Maharashtra, 407 from Delhi, 288 from Uttar Pradesh, 217 from Karnataka, 199 from Chhattisgarh, 159 from Rajasthan, 157 from Punjab, 153 each from Gujarat and Tamil Nadu, 145 from Haryana and 115 from Jharkhand.
A total of 2,18,959 deaths have been reported so far in the country including 70,284 from Maharashtra, 16,966 from Delhi, 16,011 from Karnataka, 14,346 from Tamil Nadu, 13,162 from Uttar Pradesh, 11,539 from West Bengal, 9,317 from Punjab and 9,009 from Chhattisgarh.
The health ministry stressed that more than 70 per cent of the deaths occurred due to comorbidities.
“Our figures are being reconciled with the Indian Council of Medical Research,” the ministry said on its website, adding that state-wise distribution of figures is subject to further verification and reconciliation.
With inputs from PTI